catalyst

Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acti — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2023-11-03 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acti — primary completion
Type
Trial Readout
Date
2023-11-03
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here
trial
Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005
trial